Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Gynecol Oncol. 2015 Feb 20;137(2):203–209. doi: 10.1016/j.ygyno.2015.02.013

Figure 2.

Figure 2

Figure 2

A. Kaplan-Meier analysis of overall survival for high-risk women based on receipt of chemotherapy (P<0.0001), red line chemotherapy, blue line no chemotherapy.

B. Kaplan-Meier analysis of overall survival based on duration of chemotherapy for high-risk women (P=0.14), red line chemotherapy ≤3 months, blue line chemotherapy 4-8 months.